Compare MTH & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTH | LIVN |
|---|---|---|
| Founded | 1985 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.5B |
| IPO Year | 1997 | 2015 |
| Metric | MTH | LIVN |
|---|---|---|
| Price | $64.35 | $73.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $77.63 | $72.43 |
| AVG Volume (30 Days) | ★ 846.9K | 786.6K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.82 | 0.40 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.79 |
| Revenue Next Year | $9.81 | $6.63 |
| P/E Ratio | ★ $77.90 | $184.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $58.03 | $41.02 |
| 52 Week High | $84.54 | $74.32 |
| Indicator | MTH | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 65.24 |
| Support Level | $58.57 | $61.63 |
| Resistance Level | $71.37 | N/A |
| Average True Range (ATR) | 2.11 | 2.66 |
| MACD | 0.06 | 0.59 |
| Stochastic Oscillator | 62.81 | 96.97 |
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.